| Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial M Hallek, K Fischer, G Fingerle-Rowson, AM Fink, R Busch, J Mayer, ... The Lancet 376 (9747), 1164-1174, 2010 | 2387 | 2010 |
| Multi‐Omics Factor Analysis—a framework for unsupervised integration of multi‐omics data sets R Argelaguet, B Velten, D Arnol, S Dietrich, T Zenz, JC Marioni, F Buettner, ... Molecular systems biology 14 (6), e8124, 2018 | 822 | 2018 |
| From pathogenesis to treatment of chronic lymphocytic leukaemia T Zenz, D Mertens, R Küppers, H Döhner, S Stilgenbauer Nature Reviews Cancer 10 (1), 37-50, 2010 | 784 | 2010 |
| TP53 Mutation and Survival in Chronic Lymphocytic Leukemia T Zenz, B Eichhorst, R Busch, T Denzel, S Häbe, D Winkler, A Bühler, ... Journal of Clinical Oncology 28 (29), 4473-4479, 2010 | 770 | 2010 |
| TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome FG Rücker, RF Schlenk, L Bullinger, S Kayser, V Teleanu, H Kett, ... Blood, The Journal of the American Society of Hematology 119 (9), 2114-2121, 2012 | 704 | 2012 |
| Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial S Stilgenbauer, A Schnaiter, P Paschka, T Zenz, M Rossi, K Döhner, ... Blood, The Journal of the American Society of Hematology 123 (21), 3247-3254, 2014 | 630 | 2014 |
| Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia: a multivariate analysis from the … S Böttcher, M Ritgen, K Fischer, S Stilgenbauer, RM Busch, ... Journal of clinical oncology 30 (9), 980-988, 2012 | 556 | 2012 |
| Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term … T Zenz, A Kröber, K Scherer, S Häbe, A Bühler, A Benner, T Denzel, ... Blood, The Journal of the American Society of Hematology 112 (8), 3322-3329, 2008 | 514 | 2008 |
| Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study … P Dreger, H Döhner, M Ritgen, S Böttcher, R Busch, S Dietrich, D Bunjes, ... Blood, The Journal of the American Society of Hematology 116 (14), 2438-2447, 2010 | 397 | 2010 |
| Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation … T Zenz, S Häbe, T Denzel, J Mohr, D Winkler, A Bühler, A Sarno, S Groner, ... Blood, The Journal of the American Society of Hematology 114 (13), 2589-2597, 2009 | 383 | 2009 |
| Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition JA Burger, DA Landau, A Taylor-Weiner, I Bozic, H Zhang, K Sarosiek, ... Nature communications 7 (1), 11589, 2016 | 374 | 2016 |
| Subcutaneous alemtuzumab in fludarabine-refractory chronic lymphocytic leukemia: clinical results and prognostic marker analyses from the CLL2H study of the German Chronic … S Stilgenbauer, T Zenz, D Winkler, A Buehler, RF Schlenk, S Groner, ... Journal of Clinical Oncology 27 (24), 3994-4001, 2009 | 350 | 2009 |
| miR-34a as part of the resistance network in chronic lymphocytic leukemia T Zenz, J Mohr, E Eldering, AP Kater, A Bühler, D Kienle, D Winkler, ... Blood, The Journal of the American Society of Hematology 113 (16), 3801-3808, 2009 | 349 | 2009 |
| DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia CC Oakes, M Seifert, Y Assenov, L Gu, M Przekopowitz, AS Ruppert, ... Nature genetics 48 (3), 253-264, 2016 | 322 | 2016 |
| Tumor-derived exosomes modulate PD-L1 expression in monocytes F Haderk, R Schulz, M Iskar, LL Cid, T Worst, KV Willmund, A Schulz, ... Science immunology 2 (13), eaah5509, 2017 | 291 | 2017 |
| BRAF inhibition in refractory hairy-cell leukemia S Dietrich, H Glimm, M Andrulis, C Von Kalle, AD Ho, T Zenz New England Journal of Medicine 366 (21), 2038-2040, 2012 | 289 | 2012 |
| ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia S Pospisilova, D Gonzalez, J Malcikova, M Trbusek, D Rossi, AP Kater, ... Leukemia 26 (7), 1458-1461, 2012 | 287 | 2012 |
| Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia MR Grever, O Abdel-Wahab, LA Andritsos, V Banerji, J Barrientos, ... Blood, The Journal of the American Society of Hematology 129 (5), 553-560, 2017 | 259 | 2017 |
| Targeting the BRAF V600E mutation in multiple myeloma M Andrulis, N Lehners, D Capper, R Penzel, C Heining, J Huellein, ... Cancer discovery 3 (8), 862-869, 2013 | 251 | 2013 |
| Pan-cancer analysis of whole genomes. S Hirano, L Yang, M Juul, CA Purdie, BP O'Neill, R Kabbe, ... Nature 578 (DKFZ-2020-01051), 82-93, 2020 | 233 | 2020 |
